SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-024939
Filing Date
2023-02-24
Accepted
2023-02-24 06:14:52
Documents
12
Period of Report
2023-02-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237527d2_8k.htm   iXBRL 8-K 29556
  Complete submission text file 0001104659-23-024939.txt   204133

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vygr-20230221.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20230221_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20230221_pre.xml EX-101.PRE 22617
6 EXTRACTED XBRL INSTANCE DOCUMENT tm237527d2_8k_htm.xml XML 3488
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 23662251
SIC: 2836 Biological Products, (No Diagnostic Substances)